How to Get Azelaic acid Online in Girona
Need Azelaic acid in Girona? Request an online dermatology consultation with an EU-licensed doctor. If approved, receive your official REMPE prescription in under 24 hours to present at any local pharmacy.

DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
If you want to get Azelaic acid online in Girona, you do not need to wait weeks for an in-person dermatology appointment at Hospital Universitari Dr. Josep Trueta or a local CAP clinic. Through Hi-Doctor, you can complete an asynchronous medical questionnaire with photo upload in under ten minutes. An EU-licensed doctor reviews your case within 24 hours and issues an official REMPE electronic prescription when clinically appropriate. The 40 € consultation fee is refunded in full if the doctor does not issue a prescription.
Over 50,000 patients have accessed clinical care through Hi-Doctor, maintaining a 4.8/5 Trustpilot rating across Europe.
Key takeaways
- Direct access: Request medical assessment for topical Azelaic acid 15% gel without video calls or waiting rooms.
- Transparent pricing: A 40 € one-off consultation fee that is refunded in full if the doctor determines treatment is not clinically appropriate.
- Official REMPE standard: Download your PDF prescription bearing a digital QR code verifiable under Spanish regulations and Directive 2011/24/EU.
- Strict topical scope: Severe, nodular, or scarring acne and oral treatments require in-person care and are referred out.
How it works — get your consultation in 4 steps
Obtaining an assessment to get Azelaic acid online in Girona follows an entirely asynchronous, fully auditable digital pathway designed under European clinical standards.

- Complete the clinical questionnaire: Detail your skin symptoms, medical history, allergies, and previous acne or rosacea treatments.
- Upload clear photographs: Provide well-lit images of the affected skin areas so the evaluating physician can accurately grade lesion severity.
- Physician review: An EU-registered doctor examines your answers and photographs to establish clinical suitability.
- Receive your REMPE prescription: If approved, your prescription PDF arrives in your secure account inbox and by email notification, ready to download and print or present on your mobile screen.
Who qualifies
Azelaic acid 15% gel (often prescribed under brand names such as Skinoren or Finacea) is a versatile topical agent indicated for mild-to-moderate inflammatory acne vulgaris and papulopustular rosacea. Because it does not cause photosensitivity and carries minimal risk of post-inflammatory hyperpigmentation, doctors frequently consider it an optimal first-line topical treatment for darker skin phototypes and patients who are pregnant or breastfeeding.

However, telemedicine treatment has precise clinical boundaries. Hi-Doctor provides topical dermatology solutions only. If your evaluation reveals severe nodulocystic lesions, deep scarring, or systemic involvement requiring oral isotretinoin or oral antibiotics, the doctor will decline the online prescription and refer you to in-person medical care in Girona.
What Azelaic-acid actually does
Azelaic acid exerts a multi-modal mechanism of action. It functions as a competitive inhibitor of mitochondrial oxidoreductases and 5-alpha-reductase, while exerting direct antibacterial activity against Cutibacterium acnes without triggering microbial resistance. Additionally, its comedolytic properties normalize epidermal keratinisation, clearing follicular blockages.
| Treatment Phase | Expected Clinical Timeline | Primary Biological Action |
|---|---|---|
| Weeks 1–3 | Mild initial skin adjustment; mild tingling or redness | Bacteriostatic reduction of surface microbial load |
| Weeks 4–6 | Initial reduction of microcomedones and inflammatory papules | Inhibition of follicular follicular hyperkeratinisation |
| Weeks 8–12 | Meaningful clinical change and fading of hyperpigmentation | Tyrosinase inhibition reducing post-acne macules |
Meaningful therapeutic change is judged at 12 weeks of consistent twice-daily application, not before. Do not expect overnight clearance.
Side effects and when to stop
Most patients tolerate topical Azelaic acid well, but localized cutaneous reactions can occur during the first few weeks of therapy.
- Common transient effects: Mild stinging, burning, pruritus, or dry peeling at the application site. These symptoms typically resolve as the epidermal barrier adapts.
- Management: Applying a non-comedogenic moisturiser before the gel or reducing application to once daily can mitigate irritation.
- When to stop: Discontinue use immediately and consult a doctor if you develop signs of an allergic contact reaction, such as severe erythema, facial swelling, blistering, or intense urticaria.
Why Hi-Doctor vs. walking into a clinic
Navigating public or private healthcare appointments in Girona often involves extensive administrative delays for routine topical dermatological renewals.

| Feature | Hi-Doctor Telemedicine | Traditional Clinic Visit |
|---|---|---|
| Consultation Fee | 40 € flat fee | 60 €–150 € (private specialist) |
| Physician Review Time | Under 24 hours asynchronously | 1 to 6 weeks wait time |
| Fee Policy | Consultation fee refunded in full if no prescription is issued | Non-refundable appointment fee |
| Prescription Format | Downloadable REMPE digital PDF | Paper or regional health card (CatSalut) |
COMMON QUESTIONS
Frequently asked questions
Yes. The prescription generated through Hi-Doctor utilizes Spain's official REMPE (Receta Médica Privada Electrónica) standard with a verifiable QR code. You can present the printed PDF or display it on your phone at any community pharmacy in Girona or across Spain. Under Directive 2011/24/EU and Commission Implementing Directive 2012/52/EU, it can also be presented at pharmacies across the EU, where the pharmacist reviews the document and may dispense a locally marketed equivalent, retaining the professional right to refuse dispensing.





